Regulation of P53-MDMX Interaction by Casein Kinase 1 Alpha

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2005 Jul 19

PMID 16024788

Citations 56

Authors

Lihong Chen

Changgong Li

Yu Pan

Jiandong Chen

Affiliations

Soon will be listed here.

Abstract

MDMX is a homolog of MDM2 that is critical for regulating p53 function during mouse development. MDMX degradation is regulated by MDM2-mediated ubiquitination. Whether there are other mechanisms of MDMX regulation is largely unknown. We found that MDMX binds to the casein kinase 1 alpha isoform (CK1alpha) and is phosphorylated by CK1alpha. Expression of CK1alpha stimulates the ability of MDMX to bind to p53 and inhibit p53 transcriptional function. Regulation of MDMX-p53 interaction requires CK1alpha binding to the central region of MDMX and phosphorylation of MDMX on serine 289. Inhibition of CK1alpha expression by isoform-specific small interfering RNA (siRNA) activates p53 and further enhances p53 activity after ionizing irradiation. CK1alpha siRNA also cooperates with DNA damage to induce apoptosis. These results suggest that CK1alpha is a functionally relevant MDMX-binding protein and plays an important role in regulating p53 activity in the absence or presence of stress.

Citing Articles

Casein Kinase 1α-A Target for Prostate Cancer Therapy?.

Lishman-Walker E, Coffey K Cancers (Basel). 2024; 16(13).

PMID: 39001502 PMC: 11240421. DOI: 10.3390/cancers16132436.

Casein kinase 1α mediates phosphorylation of the Merkel cell polyomavirus large T antigen for β-TrCP destruction complex interaction and subsequent degradation.

Pham A, Kwun H mBio. 2024; 15(8):e0111724.

PMID: 38940554 PMC: 11323502. DOI: 10.1128/mbio.01117-24.

Exploring the role of casein kinase 1α splice variants across cancer cell lines.

Melendez R, Wynn D, Merugu S, Singh P, Kaplan K, Robbins D Biochem Biophys Res Commun. 2024; 723:150189.

PMID: 38852281 PMC: 11287285. DOI: 10.1016/j.bbrc.2024.150189.

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector.

Lin W, Yan Y, Huang Q, Zheng D Biologics. 2024; 18:61-78.

PMID: 38318098 PMC: 10839028. DOI: 10.2147/BTT.S436629.

Targeting casein kinase 1 for cancer therapy: current strategies and future perspectives.

Long N, Lee S Front Oncol. 2023; 13:1244775.

PMID: 38023245 PMC: 10666751. DOI: 10.3389/fonc.2023.1244775.

References

Sharp D, Kratowicz S, Sank M, GEORGE D . Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J Biol Chem. 1999; 274(53):38189-96. DOI: 10.1074/jbc.274.53.38189. View

Winter M, Milne D, Dias S, Kulikov R, Knippschild U, Blattner C . Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover. Biochemistry. 2004; 43(51):16356-64. DOI: 10.1021/bi0489255. View

Midgley C, Desterro J, Saville M, Howard S, Sparks A, Hay R . An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene. 2000; 19(19):2312-23. DOI: 10.1038/sj.onc.1203593. View

Joazeiro C, Weissman A . RING finger proteins: mediators of ubiquitin ligase activity. Cell. 2000; 102(5):549-52. DOI: 10.1016/s0092-8674(00)00077-5. View

Rowan B, Garrison N, Weigel N, OMalley B . 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol Cell Biol. 2000; 20(23):8720-30. PMC: 86491. DOI: 10.1128/MCB.20.23.8720-8730.2000. View

Vousden K . p53: death star. Cell. 2000; 103(5):691-4. DOI: 10.1016/s0092-8674(00)00171-9. View

Ramos Y, Stad R, Attema J, Peltenburg L, Van Der Eb A, Jochemsen A . Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53. Cancer Res. 2001; 61(5):1839-42. View

Zhang Y, Xiong Y . Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ. 2001; 12(4):175-86. View

Jackson M, Lindstrom M, Berberich S . MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation. J Biol Chem. 2001; 276(27):25336-41. DOI: 10.1074/jbc.M010685200. View

10.

Eide E, Virshup D . Casein kinase I: another cog in the circadian clockworks. Chronobiol Int. 2001; 18(3):389-98. DOI: 10.1081/cbi-100103963. View

11.

Parant J, Little N, Yan W, Reinke V, Jochemsen A, Lozano G . Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet. 2001; 29(1):92-5. DOI: 10.1038/ng714. View

12.

Desagher S, Osen-Sand A, Montessuit S, Magnenat E, Vilbois F, HOCHMANN A . Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell. 2001; 8(3):601-11. DOI: 10.1016/s1097-2765(01)00335-5. View

13.

Tzivion G, Shen Y, Zhu J . 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene. 2001; 20(44):6331-8. DOI: 10.1038/sj.onc.1204777. View

14.

Stad R, Little N, Xirodimas D, Frenk R, Van Der Eb A, Lane D . Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2001; 2(11):1029-34. PMC: 1084126. DOI: 10.1093/embo-reports/kve227. View

15.

Tzivion G, Avruch J . 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem. 2001; 277(5):3061-4. DOI: 10.1074/jbc.R100059200. View

16.

Liu C, Li Y, Semenov M, Han C, Baeg G, Tan Y . Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 2002; 108(6):837-47. DOI: 10.1016/s0092-8674(02)00685-2. View

17.

Amit S, Hatzubai A, Birman Y, Andersen J, Ben-Shushan E, Mann M . Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 2002; 16(9):1066-76. PMC: 186245. DOI: 10.1101/gad.230302. View

18.

Gu J, Kawai H, Nie L, Kitao H, Wiederschain D, Jochemsen A . Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J Biol Chem. 2002; 277(22):19251-4. DOI: 10.1074/jbc.C200150200. View

19.

Finch R, Donoviel D, Potter D, Shi M, Fan A, Freed D . mdmx is a negative regulator of p53 activity in vivo. Cancer Res. 2002; 62(11):3221-5. View

20.

Migliorini D, Denchi E, Danovi D, Jochemsen A, Capillo M, Gobbi A . Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol Cell Biol. 2002; 22(15):5527-38. PMC: 133932. DOI: 10.1128/MCB.22.15.5527-5538.2002. View